Nifty

:

11419.25

Sensex

:

38337.01

-177.65 (-1.53%)
-560.45 (-1.44%)

Login

Nifty
Sensex

:
:

11419.25
38337.01

-177.65 (-1.53%)
-560.45 (-1.44%)

Sun Pharma Advanced Research Company Ltd.

Miscellaneous

Rating :

45/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

151.20

-3.65 (-2.36%)

19-Jul-2019 | 3:59PM

Day's Open
Day's High
Day's Low
Previous Close

154.50
157.50
149.55
154.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2710105
4097.68
414.00
112.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,959.54
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,960.50
N/A
13.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.22
3.26
0.34

EBITDA CAGR (%)

10 Years
5 Years
3 Years

22.99
33.94
4.28

PAT CAGR (%)

10 Years
5 Years
3 Years

21.04
29.77
6.90

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

45.57
62.16
32.53

EV:EBITDA (Average)

8 Years
5 Years
3 Years

5.53
-15.96
-52.91

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var%
Net Sales 84.83 20.09 322.25% 19.88 19.42 2.37% 61.35 15.36 299.41% 16.81 23.39 -28.13%
Expenses 96.75 65.08 48.66% 90.26 77.60 16.31% 66.55 76.84 -13.39% 80.60 101.36 -20.48%
EBITDA -11.92 -44.99 - -70.38 -58.18 - -5.20 -61.48 - -63.79 -77.97 -
EBIDTM -14.05% -223.94% -353.97% -299.59% -8.48% -400.26% -379.48% -333.35%
Other Income 4.43 0.52 751.92% 3.27 2.15 52.09% 4.57 1.01 352.48% 1.23 1.26 -2.38%
Interest 0.04 0.01 300.00% 0.02 0.02 0.00% 0.01 0.02 -50.00% 0.02 0.07 -71.43%
Depreciation 1.82 2.02 -9.90% 1.90 2.02 -5.94% 1.94 2.08 -6.73% 1.90 2.06 -7.77%
PBT -9.35 2.48 - -69.02 -58.07 - -2.58 -62.57 - -64.48 -78.84 -
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -9.35 2.48 - -69.02 -58.07 - -2.58 -62.57 - -64.48 -78.84 -
PATM -11.02% 12.34% -347.18% -299.02% -4.21% -407.36% -383.58% -337.07%
EPS -0.36 0.10 - -2.70 -2.31 - -0.10 -2.53 - -2.57 -3.19 -

Description Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 34.30 Net Sales Growth - 133.67% -56.77% 12.24% 3.56% -6.76% 91.37% 201.17% -50.33% 70.12% Cost Of Goods Sold - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit - 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 34.30 GP Margin - 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure - 334.16 320.87 303.72 224.48 190.83 133.54 104.04 98.92 64.98 53.40 Power & Fuel Cost - 5.08 4.92 4.67 4.49 4.78 3.95 3.85 3.35 2.76 2.79 % Of Sales - 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% 4.41% 11.56% 4.73% 8.13% Employee Cost - 81.06 100.92 84.30 56.60 45.79 40.40 36.55 30.43 25.67 19.91 % Of Sales - 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% 41.88% 105.00% 43.99% 58.05% Manufacturing Exp. - 17.81 35.66 33.41 26.42 17.96 16.19 15.84 12.99 13.07 12.43 % Of Sales - 9.74% 45.57% 18.46% 16.38% 11.53% 9.69% 18.15% 44.82% 22.40% 36.24% General & Admin Exp. - 221.40 177.31 176.28 131.88 119.37 71.71 46.26 51.31 22.72 17.54 % Of Sales - 121.07% 226.57% 97.38% 81.77% 76.65% 42.93% 53.00% 177.05% 38.94% 51.14% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 8.80 2.05 5.06 5.08 2.94 1.29 1.54 0.85 0.76 0.00 % Of Sales - 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% 1.76% 2.93% 1.30% 2.10% EBITDA - -151.29 -242.61 -122.70 -63.20 -35.09 33.49 -16.76 -69.94 -6.63 -19.10 EBITDA Margin - -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% -19.20% -241.34% -11.36% -55.69% Other Income - 13.51 4.94 13.72 2.94 3.03 10.00 1.62 1.15 1.24 0.33 Interest - 0.09 0.12 1.82 2.16 0.22 5.60 3.95 0.27 0.13 0.18 Depreciation - 7.55 8.18 8.24 7.58 7.24 3.57 3.40 3.16 2.99 2.60 PBT - -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 -21.54 Tax - 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 -0.01 0.01 Tax Rate - 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% 0.00% 0.00% 0.12% -0.05% PAT - -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 -21.55 PAT before Minority Interest - -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 -21.55 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% -25.77% -249.24% -14.57% -62.83% PAT Growth - - - - - - - - - - Unadjusted EPS - -5.69 -7.94 -4.84 -2.96 -1.67 1.28 -1.03 -3.43 -0.41 -1.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 296.24 184.72 158.16 31.80 99.80 139.30 108.43 -66.61 5.62 14.12 Share Capital 26.21 25.09 24.69 23.67 23.67 23.67 23.66 20.71 20.71 20.71 Total Reserves 270.03 67.96 133.47 6.23 76.13 115.63 84.77 -87.32 -15.09 -6.59 Non-Current Liabilities 11.20 11.98 10.36 10.02 9.72 9.45 6.32 7.23 7.48 2.13 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 1.09 1.64 2.18 2.73 3.27 3.82 4.36 5.74 6.30 2.13 Long Term Provisions 10.11 10.34 8.18 7.30 6.37 5.48 1.73 1.24 1.06 0.00 Current Liabilities 95.04 116.11 108.03 124.84 37.15 38.79 94.24 145.03 64.66 56.02 Trade Payables 82.92 102.48 94.45 58.15 27.01 29.75 12.79 16.23 10.31 10.99 Other Current Liabilities 7.66 9.42 9.81 12.09 8.98 7.58 3.79 66.06 53.17 42.70 Short Term Borrowings 0.00 0.10 0.41 52.48 0.40 0.82 75.97 61.94 0.29 0.00 Short Term Provisions 4.46 4.10 3.35 2.12 0.77 0.64 1.69 0.79 0.89 2.33 Total Liabilities 402.48 312.81 276.55 166.66 146.67 187.54 208.99 85.65 77.76 72.27 Net Block 57.56 51.74 69.16 69.96 66.79 64.49 65.55 63.93 62.93 60.89 Gross Block 80.22 67.17 77.28 106.82 96.38 86.98 84.57 79.58 75.45 70.53 Accumulated Depreciation 22.66 15.44 8.12 36.86 29.58 22.49 19.02 15.65 12.52 9.64 Non Current Assets 145.09 137.59 118.27 98.88 83.46 76.87 69.14 66.97 65.27 62.91 Capital Work in Progress 24.13 3.27 1.47 0.87 0.02 0.76 0.16 1.14 1.26 2.03 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 63.29 82.48 47.45 27.99 16.55 11.50 3.30 1.69 0.89 0.00 Other Non Current Assets 0.12 0.10 0.19 0.07 0.09 0.11 0.13 0.21 0.19 0.00 Current Assets 257.38 175.22 158.28 66.59 62.93 110.12 139.01 18.24 12.50 9.36 Current Investments 210.58 107.57 9.65 0.00 0.00 6.50 96.91 0.00 2.47 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 10.17 17.56 38.90 9.16 19.89 28.00 25.06 4.26 2.63 0.50 Cash & Bank 0.68 1.32 70.31 12.75 17.34 6.56 6.72 6.50 5.15 5.35 Other Current Assets 35.96 2.04 1.95 1.34 25.70 69.06 10.33 7.48 2.25 3.51 Short Term Loans & Adv. 33.39 46.73 37.48 43.35 24.27 63.34 9.69 7.15 2.02 3.51 Net Current Assets 162.34 59.11 50.25 -58.24 25.79 71.33 44.77 -126.79 -52.16 -46.66 Total Assets 402.47 312.81 276.55 166.65 146.67 187.55 208.99 85.64 77.77 72.27

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity -171.91 -182.77 -128.04 -44.21 -41.17 36.90 -95.34 -69.45 2.29 12.65 PBT -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 -21.54 Adjustment -21.77 3.82 -1.14 9.25 4.73 0.90 5.71 2.87 2.70 3.94 Changes in Working Capital -0.17 20.48 12.86 30.41 -3.74 9.80 -77.91 0.70 8.14 30.27 Cash after chg. in Working capital -167.38 -221.68 -107.32 -30.34 -38.53 45.03 -94.69 -68.66 2.33 12.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 -0.65 -0.79 -0.03 -0.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 48.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -102.19 -104.62 -6.61 -13.08 53.00 43.59 -99.31 -2.42 -7.64 -12.18 Net Fixed Assets -33.91 8.31 28.94 -11.29 -8.66 -3.01 -4.01 -4.01 -4.15 -8.15 Net Investments -103.01 -97.92 -9.65 0.00 6.50 90.41 -96.91 2.47 -2.47 0.00 Others 34.73 -15.01 -25.90 -1.79 55.16 -43.81 1.61 -0.88 -1.02 -4.03 Cash from Financing Activity 274.25 224.01 194.25 50.55 -1.26 -80.84 194.38 72.10 4.41 0.28 Net Cash Inflow / Outflow 0.15 -63.38 59.60 -6.74 10.57 -0.35 -0.27 0.23 -0.93 0.75 Opening Cash & Equivalents 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34 1.27 0.52 Closing Cash & Equivalent 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34 1.27

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 11.30 3.71 6.41 1.21 4.18 5.82 4.52 -3.16 0.27 0.67 ROA -40.66% -66.85% -53.72% -44.68% -23.65% 15.29% -15.27% -88.40% -11.33% -32.18% ROE -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% -110.94% 0.00% -86.09% -86.56% ROCE -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% -19.55% -1066.48% -58.87% -79.66% Fixed Asset Turnover 2.48 1.08 1.97 1.59 1.70 1.95 1.06 0.37 0.80 0.53 Receivable days 27.67 131.66 48.45 32.87 56.11 57.97 61.31 43.42 9.80 5.39 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 300.15 238.43 211.37 163.03 136.14 120.80 88.65 96.96 87.32 83.14 Cash Conversion Cycle -272.48 -106.77 -162.92 -130.16 -80.03 -62.83 -27.34 -53.54 -77.52 -77.76 Total Debt/Equity 0.01 0.02 0.02 1.94 0.04 0.04 0.75 -1.02 1.17 0.15 Interest Cover -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13 -4.69 -261.76 -65.47 -122.11

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd

seafarer overseas growth and income fund

Annual Reports:

News Update:

SPARC gets Orphan Drug Designation from USFDA
8th Jul 2019, 11:44 AM

The company has received Orphan Drug Designation for SCO-088 for the treatment of patients with Chronic Myeloid Leukemia
Read More
USFDA accepts to review SPARC’s NDA for Taclantis
1st Jul 2019, 10:46 AM

The USFDA confirmed that this NDA will be a standard review
Read More
Sun Pharma Adv. Res - Quarterly Results
7th May 2019, 14:20 PM

Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback